IMMUNOME INC. (IMNM) SEC News Aug. 11, 2026, 20:05 UTC (30% Negative) IMMUNOME INC. (IMNM) Reports Q3 2026 Financial Results Full text
Register to leave comments News bot Aug. 11, 2026, 8:07 p.m. 📋 IMMUNOME INC. (IMNM) - Financial Results Filing Date: 2026-08-11 Accepted: 2026-08-11 16:05:17 Event Type: Financial Results Event Details: IMMUNOME INC. (IMNM) Reports the reporting period Financial Results IMMUNOME INC. (IMNM) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: 4015 Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: 217706 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2026 2025 Change ($) Change (%) Current Assets Prepaid Expenses Other Current Assets 18.45K 7.29K $11.16K +152.95% Current Assets Property Equipment Net 17.36K 14.64K $2.72K +18.60% Current Liabilities Accounts Payable 6.00K 3.34K $2.66K +79.57% Operating Expenses Loss From Operations 78.14K 46.48K $31.66K +68.11% Operating Expenses Interest Income 5.01K 3.08K $1.93K +62.54% Operating Expenses Net Loss 73.13K 43.40K $29.73K +68.51% Operating Expenses Net Loss Per Share 0.65 0.50 $0.15 +30.00% Comprehensive Loss Net Loss 73.13K 43.40K $29.73K +68.51% Prepaid Expenses and Other Current Assets 18.45K 7.29K $11.16K +152.95% Property and Equipment, Net 17.36K 14.64K $2.72K +18.60% Accounts Payable 6.00K 3.34K $2.66K +79.57% Operating Lease Liabilities 4.59K 3.85K $733.00 +19.01% Loss from Operations 78.14K 46.48K $31.66K +68.11% Interest Income 5.01K 3.08K $1.93K +62.54% Net Loss 73.13K 43.40K $29.73K +68.51% 💼 Business Developments: PartnershipAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: IMMUNOME INC.Ticker Symbol: IMNM
📋 IMMUNOME INC. (IMNM) - Financial Results
Filing Date: 2026-08-11
Accepted: 2026-08-11 16:05:17
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: